Holen Sie sich die Stockscreener-App
0.4674
7.46%
-0.0431
Handel nachbörslich:
.47
0.0026
+0.56%
Schlusskurs vom Vortag:
$0.5105
Offen:
$0.5056
24-Stunden-Volumen:
2.39M
Relative Volume:
0.71
Marktkapitalisierung:
$18.99M
Einnahmen:
$653.40K
Nettoeinkommen (Verlust:
$-20.19M
KGV:
-0.2584
EPS:
-1.8091
Netto-Cashflow:
$-11.11M
1W Leistung:
+19.23%
1M Leistung:
+9.10%
6M Leistung:
-49.93%
1J Leistung:
-61.90%
1-Tages-Spanne:
$0.4318
$0.5533
1-Wochen-Bereich:
$0.382
$0.6443
52-Wochen-Spanne:
$0.372
$3.1699
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, RDGT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.4674 | 20.74M | 653.40K | -20.19M | -11.11M | -1.8091 |
|
HITI
High Tide Inc
|
2.46 | 213.45M | 424.38M | -36.94M | 9.53M | -0.4206 |
|
PETS
Petmed Express Inc
|
2.46 | 52.00M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
POM
Pomdoctor Ltd Adr
|
0.3961 | 45.69M | 0 | 0 | 0 | 0.00 |
|
RDGT
Ridgetech Inc
|
2.2086 | 36.57M | 119.97M | -1.45M | 632.50K | -0.9847 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings (SCNX) Co-CEO granted 500,000 restricted shares - Stock Titan
Scienture secures GPO deals for naloxone nasal spray - Investing.com India
Scienture secures GPO deals for naloxone nasal spray By Investing.com - Investing.com Nigeria
SCNX Expands Market Reach with New GPO Agreements - GuruFocus
SCIENTURE Broadens Commercial Access for REZENOPY, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - Bitget
SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - The Manila Times
High-dose overdose spray REZENOPY set to reach 5,000 US care sites - Stock Titan
EXCLUSIVE: Scienture Expands Reach For Opioid Overdose Treatment, With Deals Covering 60% Of US Institutional Market - Benzinga
What makes Scienture Holdings Inc. stock attractive to growth funds2025 AllTime Highs & High Conviction Buy Zone Alerts - Naître et grandir
Why Scienture Holdings Inc. stock remains a top recommendationMarket Activity Recap & Daily Profit Focused Stock Screening - Naître et grandir
Is Scienture Holdings Inc. stock a top pick in earnings seasonWeekly Trade Review & Proven Capital Preservation Tips - Naître et grandir
Why Is Scienture Stock Rising Today? - Stocktwits
SCNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SCNX Earnings History & Surprises | EPS & Revenue Results | SCIENTURE HOLDINGS INC (NASDAQ:SCNX) - ChartMill
Aug Spikes: What is Scienture Holdings Incs market position2025 Big Picture & Community Supported Trade Ideas - baoquankhu1.vn
SCNX Should I Buy - Intellectia AI
Scienture Holdings, Inc.: Target Price Consensus and Analysts Recommendations | | US80880X1046 - marketscreener.com
Scienture Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | | US80880X1046 - marketscreener.com
SCNX Technical Analysis & Stock Price Forecast - Intellectia AI
Scienture Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | SCNX | US80880X1046 - marketscreener.com
Scienture (NASDAQ:SCNX) Coverage Initiated by Analysts at Maxim Group - Defense World
Maxim Group Initiates Coverage on Scienture Holdings (SCNX) with a 'Buy' Rating | SCNX Stock News - GuruFocus
Maxim Group Initiates Coverage of Scienture Holdings (SCNX) with Buy Recommendation - Nasdaq
What are analysts’ price targets for Scienture Holdings Inc.2025 Year in Review & Fast Gaining Stock Reports - mfd.ru
Aug Movers: What is Scienture Holdings Incs market positionWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Gainers Report: What is Scienture Holdings Incs market positionBond Market & Weekly Breakout Stock Alerts - baoquankhu1.vn
Why Scienture Holdings Inc. (4E4) stock is upgraded to buyProfit Target & Long-Term Safe Investment Plans - mfd.ru
Is Scienture Holdings Inc. stock a good pick for beginnersJuly 2025 Highlights & Low Risk Profit Maximizing Plans - mfd.ru
Aug Levels: Is Scienture Holdings Inc stock heavily shortedWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn
Scienture reports progress on ARBLI, confirms REZENOPY launch By Investing.com - Investing.com Nigeria
SCNX: Scienture Updates on Arbli and Future Product Launch - GuruFocus
Scienture reports progress on ARBLI, confirms REZENOPY launch - Investing.com
SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times
Scienture Provides Commercial Update on ARBLI , the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium - marketscreener.com
Signal Recap: Does InvenTrust Properties Corp stock have upside surprise potentialAnalyst Downgrade & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Is Scienture Holdings Inc gaining market share2025 Technical Overview & AI Enhanced Trading Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Scienture appoints Hariharan, Mani as co-CEOs - MSN
Growth Value: Will Scienture Holdings Inc benefit from geopolitical trendsWeekly Trading Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
EPS Watch: What is Scienture Holdings Incs book value per share2025 Technical Overview & Expert Approved Momentum Ideas - baoquankhu1.vn
Risk On: Is Scienture Holdings Inc stock heavily shortedMarket Risk Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Will Scienture Holdings Inc. stock recover faster than peersQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com
Aug Spikes: Is EHTH stock forming a cup and handleOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment - Sahm
Head to Head Review: Scienture (NASDAQ:SCNX) & Aldeyra Therapeutics (NASDAQ:ALDX) - Defense World
Scienture receives patent for high-dose naloxone nasal spray By Investing.com - Investing.com Nigeria
Scienture And Summit's REZENOPY Awarded Orange Book-Listable Patent, Valid Till 2041 - Nasdaq
SCNX Secures Patent for REZENOPY Nasal Spray Until 2041 - GuruFocus
Scienture receives patent for high-dose naloxone nasal spray - Investing.com
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment - The Manila Times
New patent backs 10 mg naloxone spray for life-saving overdose treatment - Stock Titan
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.73%
2.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):